The global market for Neurodegenerative Disease IVD was valued at US$ 462 million in the year 2024 and is projected to reach a revised size of US$ 670 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Neurodegenerative Disease IVD Market

Neurodegenerative disease IVD (In Vitro Diagnostics) refers to an in vitro detection method and technology system that detects specific biomarkers in biological samples (such as cerebrospinal fluid, blood, urine, etc.) and combines high-sensitivity detection technology to achieve early diagnosis, disease monitoring and prognosis evaluation of neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD). Its core goal is to solve the problems of insufficient sensitivity, strong invasiveness or high cost of traditional diagnostic methods (such as clinical evaluation and imaging examinations), and promote early intervention and precision treatment of diseases.

North American market for Neurodegenerative Disease IVD is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Neurodegenerative Disease IVD is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Neurodegenerative Disease IVD in Alzheimer's Disease is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Neurodegenerative Disease IVD include ADx Neurosciences, Analytik Jena, Beckman Coulter, Creative Biolabs, Fujirebio, Genemedi, Medix Biochemica, Revvity, Roche Diagnostics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Neurodegenerative Disease IVD, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurodegenerative Disease IVD.

The Neurodegenerative Disease IVD market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neurodegenerative Disease IVD market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Neurodegenerative Disease IVD companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Neurodegenerative Disease IVD Market Report

Report Metric	Details
Report Name	Neurodegenerative Disease IVD Market
Accounted market size in year	US$ 462 million
Forecasted market size in 2031	US$ 670 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Protein Biomarker Detection Nucleic Acid Biomarker Detection Others
Segment by Application	Alzheimer's Disease Parkinson's Disease Huntington's Disease Amyotrophic Lateral Sclerosis (ALS) Multiple System Atrophy (MSA) Progressive Supranuclear Palsy (PSP) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ADx Neurosciences, Analytik Jena, Beckman Coulter, Creative Biolabs, Fujirebio, Genemedi, Medix Biochemica, Revvity, Roche Diagnostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neurodegenerative Disease IVD company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Neurodegenerative Disease IVD Market growing?

Ans: The Neurodegenerative Disease IVD Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Neurodegenerative Disease IVD Market size in 2031?

Ans: The Neurodegenerative Disease IVD Market size in 2031 will be US$ 670 million.

Who are the main players in the Neurodegenerative Disease IVD Market report?

Ans: The main players in the Neurodegenerative Disease IVD Market are ADx Neurosciences, Analytik Jena, Beckman Coulter, Creative Biolabs, Fujirebio, Genemedi, Medix Biochemica, Revvity, Roche Diagnostics

What are the Application segmentation covered in the Neurodegenerative Disease IVD Market report?

Ans: The Applications covered in the Neurodegenerative Disease IVD Market report are Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), Others

What are the Type segmentation covered in the Neurodegenerative Disease IVD Market report?

Ans: The Types covered in the Neurodegenerative Disease IVD Market report are Protein Biomarker Detection, Nucleic Acid Biomarker Detection, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Neurodegenerative Disease IVD Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Protein Biomarker Detection

1.2.3 Nucleic Acid Biomarker Detection

1.2.4 Others

1.3 Market by Application

1.3.1 Global Neurodegenerative Disease IVD Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Alzheimer's Disease

1.3.3 Parkinson's Disease

1.3.4 Huntington's Disease

1.3.5 Amyotrophic Lateral Sclerosis (ALS)

1.3.6 Multiple System Atrophy (MSA)

1.3.7 Progressive Supranuclear Palsy (PSP)

1.3.8 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Neurodegenerative Disease IVD Market Perspective (2020-2031)

2.2 Global Neurodegenerative Disease IVD Growth Trends by Region

2.2.1 Global Neurodegenerative Disease IVD Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Neurodegenerative Disease IVD Historic Market Size by Region (2020-2025)

2.2.3 Neurodegenerative Disease IVD Forecasted Market Size by Region (2026-2031)

2.3 Neurodegenerative Disease IVD Market Dynamics

2.3.1 Neurodegenerative Disease IVD Industry Trends

2.3.2 Neurodegenerative Disease IVD Market Drivers

2.3.3 Neurodegenerative Disease IVD Market Challenges

2.3.4 Neurodegenerative Disease IVD Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Neurodegenerative Disease IVD Players by Revenue

3.1.1 Global Top Neurodegenerative Disease IVD Players by Revenue (2020-2025)

3.1.2 Global Neurodegenerative Disease IVD Revenue Market Share by Players (2020-2025)

3.2 Global Top Neurodegenerative Disease IVD Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Neurodegenerative Disease IVD Revenue

3.4 Global Neurodegenerative Disease IVD Market Concentration Ratio

3.4.1 Global Neurodegenerative Disease IVD Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Neurodegenerative Disease IVD Revenue in 2024

3.5 Global Key Players of Neurodegenerative Disease IVD Head office and Area Served

3.6 Global Key Players of Neurodegenerative Disease IVD, Product and Application

3.7 Global Key Players of Neurodegenerative Disease IVD, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Neurodegenerative Disease IVD Breakdown Data by Type

4.1 Global Neurodegenerative Disease IVD Historic Market Size by Type (2020-2025)

4.2 Global Neurodegenerative Disease IVD Forecasted Market Size by Type (2026-2031)

5 Neurodegenerative Disease IVD Breakdown Data by Application

5.1 Global Neurodegenerative Disease IVD Historic Market Size by Application (2020-2025)

5.2 Global Neurodegenerative Disease IVD Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Neurodegenerative Disease IVD Market Size (2020-2031)

6.2 North America Neurodegenerative Disease IVD Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Neurodegenerative Disease IVD Market Size by Country (2020-2025)

6.4 North America Neurodegenerative Disease IVD Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Neurodegenerative Disease IVD Market Size (2020-2031)

7.2 Europe Neurodegenerative Disease IVD Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Neurodegenerative Disease IVD Market Size by Country (2020-2025)

7.4 Europe Neurodegenerative Disease IVD Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Neurodegenerative Disease IVD Market Size (2020-2031)

8.2 Asia-Pacific Neurodegenerative Disease IVD Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Neurodegenerative Disease IVD Market Size by Region (2020-2025)

8.4 Asia-Pacific Neurodegenerative Disease IVD Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Neurodegenerative Disease IVD Market Size (2020-2031)

9.2 Latin America Neurodegenerative Disease IVD Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Neurodegenerative Disease IVD Market Size by Country (2020-2025)

9.4 Latin America Neurodegenerative Disease IVD Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Neurodegenerative Disease IVD Market Size (2020-2031)

10.2 Middle East & Africa Neurodegenerative Disease IVD Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Neurodegenerative Disease IVD Market Size by Country (2020-2025)

10.4 Middle East & Africa Neurodegenerative Disease IVD Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ADx Neurosciences

11.1.1 ADx Neurosciences Company Details

11.1.2 ADx Neurosciences Business Overview

11.1.3 ADx Neurosciences Neurodegenerative Disease IVD Introduction

11.1.4 ADx Neurosciences Revenue in Neurodegenerative Disease IVD Business (2020-2025)

11.1.5 ADx Neurosciences Recent Development

11.2 Analytik Jena

11.2.1 Analytik Jena Company Details

11.2.2 Analytik Jena Business Overview

11.2.3 Analytik Jena Neurodegenerative Disease IVD Introduction

11.2.4 Analytik Jena Revenue in Neurodegenerative Disease IVD Business (2020-2025)

11.2.5 Analytik Jena Recent Development

11.3 Beckman Coulter

11.3.1 Beckman Coulter Company Details

11.3.2 Beckman Coulter Business Overview

11.3.3 Beckman Coulter Neurodegenerative Disease IVD Introduction

11.3.4 Beckman Coulter Revenue in Neurodegenerative Disease IVD Business (2020-2025)

11.3.5 Beckman Coulter Recent Development

11.4 Creative Biolabs

11.4.1 Creative Biolabs Company Details

11.4.2 Creative Biolabs Business Overview

11.4.3 Creative Biolabs Neurodegenerative Disease IVD Introduction

11.4.4 Creative Biolabs Revenue in Neurodegenerative Disease IVD Business (2020-2025)

11.4.5 Creative Biolabs Recent Development

11.5 Fujirebio

11.5.1 Fujirebio Company Details

11.5.2 Fujirebio Business Overview

11.5.3 Fujirebio Neurodegenerative Disease IVD Introduction

11.5.4 Fujirebio Revenue in Neurodegenerative Disease IVD Business (2020-2025)

11.5.5 Fujirebio Recent Development

11.6 Genemedi

11.6.1 Genemedi Company Details

11.6.2 Genemedi Business Overview

11.6.3 Genemedi Neurodegenerative Disease IVD Introduction

11.6.4 Genemedi Revenue in Neurodegenerative Disease IVD Business (2020-2025)

11.6.5 Genemedi Recent Development

11.7 Medix Biochemica

11.7.1 Medix Biochemica Company Details

11.7.2 Medix Biochemica Business Overview

11.7.3 Medix Biochemica Neurodegenerative Disease IVD Introduction

11.7.4 Medix Biochemica Revenue in Neurodegenerative Disease IVD Business (2020-2025)

11.7.5 Medix Biochemica Recent Development

11.8 Revvity

11.8.1 Revvity Company Details

11.8.2 Revvity Business Overview

11.8.3 Revvity Neurodegenerative Disease IVD Introduction

11.8.4 Revvity Revenue in Neurodegenerative Disease IVD Business (2020-2025)

11.8.5 Revvity Recent Development

11.9 Roche Diagnostics

11.9.1 Roche Diagnostics Company Details

11.9.2 Roche Diagnostics Business Overview

11.9.3 Roche Diagnostics Neurodegenerative Disease IVD Introduction

11.9.4 Roche Diagnostics Revenue in Neurodegenerative Disease IVD Business (2020-2025)

11.9.5 Roche Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Neurodegenerative Disease IVD Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Protein Biomarker Detection

Table 3. Key Players of Nucleic Acid Biomarker Detection

Table 4. Key Players of Others

Table 5. Global Neurodegenerative Disease IVD Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Neurodegenerative Disease IVD Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Neurodegenerative Disease IVD Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Neurodegenerative Disease IVD Market Share by Region (2020-2025)

Table 9. Global Neurodegenerative Disease IVD Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Neurodegenerative Disease IVD Market Share by Region (2026-2031)

Table 11. Neurodegenerative Disease IVD Market Trends

Table 12. Neurodegenerative Disease IVD Market Drivers

Table 13. Neurodegenerative Disease IVD Market Challenges

Table 14. Neurodegenerative Disease IVD Market Restraints

Table 15. Global Neurodegenerative Disease IVD Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Neurodegenerative Disease IVD Market Share by Players (2020-2025)

Table 17. Global Top Neurodegenerative Disease IVD Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurodegenerative Disease IVD as of 2024)

Table 18. Ranking of Global Top Neurodegenerative Disease IVD Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Neurodegenerative Disease IVD Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Neurodegenerative Disease IVD, Headquarters and Area Served

Table 21. Global Key Players of Neurodegenerative Disease IVD, Product and Application

Table 22. Global Key Players of Neurodegenerative Disease IVD, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Neurodegenerative Disease IVD Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Neurodegenerative Disease IVD Revenue Market Share by Type (2020-2025)

Table 26. Global Neurodegenerative Disease IVD Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Neurodegenerative Disease IVD Revenue Market Share by Type (2026-2031)

Table 28. Global Neurodegenerative Disease IVD Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Neurodegenerative Disease IVD Revenue Market Share by Application (2020-2025)

Table 30. Global Neurodegenerative Disease IVD Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Neurodegenerative Disease IVD Revenue Market Share by Application (2026-2031)

Table 32. North America Neurodegenerative Disease IVD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Neurodegenerative Disease IVD Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Neurodegenerative Disease IVD Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Neurodegenerative Disease IVD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Neurodegenerative Disease IVD Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Neurodegenerative Disease IVD Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Neurodegenerative Disease IVD Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Neurodegenerative Disease IVD Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Neurodegenerative Disease IVD Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Neurodegenerative Disease IVD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Neurodegenerative Disease IVD Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Neurodegenerative Disease IVD Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Neurodegenerative Disease IVD Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Neurodegenerative Disease IVD Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Neurodegenerative Disease IVD Market Size by Country (2026-2031) & (US$ Million)

Table 47. ADx Neurosciences Company Details

Table 48. ADx Neurosciences Business Overview

Table 49. ADx Neurosciences Neurodegenerative Disease IVD Product

Table 50. ADx Neurosciences Revenue in Neurodegenerative Disease IVD Business (2020-2025) & (US$ Million)

Table 51. ADx Neurosciences Recent Development

Table 52. Analytik Jena Company Details

Table 53. Analytik Jena Business Overview

Table 54. Analytik Jena Neurodegenerative Disease IVD Product

Table 55. Analytik Jena Revenue in Neurodegenerative Disease IVD Business (2020-2025) & (US$ Million)

Table 56. Analytik Jena Recent Development

Table 57. Beckman Coulter Company Details

Table 58. Beckman Coulter Business Overview

Table 59. Beckman Coulter Neurodegenerative Disease IVD Product

Table 60. Beckman Coulter Revenue in Neurodegenerative Disease IVD Business (2020-2025) & (US$ Million)

Table 61. Beckman Coulter Recent Development

Table 62. Creative Biolabs Company Details

Table 63. Creative Biolabs Business Overview

Table 64. Creative Biolabs Neurodegenerative Disease IVD Product

Table 65. Creative Biolabs Revenue in Neurodegenerative Disease IVD Business (2020-2025) & (US$ Million)

Table 66. Creative Biolabs Recent Development

Table 67. Fujirebio Company Details

Table 68. Fujirebio Business Overview

Table 69. Fujirebio Neurodegenerative Disease IVD Product

Table 70. Fujirebio Revenue in Neurodegenerative Disease IVD Business (2020-2025) & (US$ Million)

Table 71. Fujirebio Recent Development

Table 72. Genemedi Company Details

Table 73. Genemedi Business Overview

Table 74. Genemedi Neurodegenerative Disease IVD Product

Table 75. Genemedi Revenue in Neurodegenerative Disease IVD Business (2020-2025) & (US$ Million)

Table 76. Genemedi Recent Development

Table 77. Medix Biochemica Company Details

Table 78. Medix Biochemica Business Overview

Table 79. Medix Biochemica Neurodegenerative Disease IVD Product

Table 80. Medix Biochemica Revenue in Neurodegenerative Disease IVD Business (2020-2025) & (US$ Million)

Table 81. Medix Biochemica Recent Development

Table 82. Revvity Company Details

Table 83. Revvity Business Overview

Table 84. Revvity Neurodegenerative Disease IVD Product

Table 85. Revvity Revenue in Neurodegenerative Disease IVD Business (2020-2025) & (US$ Million)

Table 86. Revvity Recent Development

Table 87. Roche Diagnostics Company Details

Table 88. Roche Diagnostics Business Overview

Table 89. Roche Diagnostics Neurodegenerative Disease IVD Product

Table 90. Roche Diagnostics Revenue in Neurodegenerative Disease IVD Business (2020-2025) & (US$ Million)

Table 91. Roche Diagnostics Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Neurodegenerative Disease IVD Picture

Figure 2. Global Neurodegenerative Disease IVD Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Neurodegenerative Disease IVD Market Share by Type: 2024 VS 2031

Figure 4. Protein Biomarker Detection Features

Figure 5. Nucleic Acid Biomarker Detection Features

Figure 6. Others Features

Figure 7. Global Neurodegenerative Disease IVD Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Neurodegenerative Disease IVD Market Share by Application: 2024 VS 2031

Figure 9. Alzheimer's Disease Case Studies

Figure 10. Parkinson's Disease Case Studies

Figure 11. Huntington's Disease Case Studies

Figure 12. Amyotrophic Lateral Sclerosis (ALS) Case Studies

Figure 13. Multiple System Atrophy (MSA) Case Studies

Figure 14. Progressive Supranuclear Palsy (PSP) Case Studies

Figure 15. Others Case Studies

Figure 16. Neurodegenerative Disease IVD Report Years Considered

Figure 17. Global Neurodegenerative Disease IVD Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Neurodegenerative Disease IVD Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Neurodegenerative Disease IVD Market Share by Region: 2024 VS 2031

Figure 20. Global Neurodegenerative Disease IVD Market Share by Players in 2024

Figure 21. Global Neurodegenerative Disease IVD Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Neurodegenerative Disease IVD Revenue in 2024

Figure 23. North America Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Neurodegenerative Disease IVD Market Share by Country (2020-2031)

Figure 25. United States Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Neurodegenerative Disease IVD Market Share by Country (2020-2031)

Figure 29. Germany Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Ireland Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Neurodegenerative Disease IVD Market Share by Region (2020-2031)

Figure 37. China Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia & New Zealand Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Neurodegenerative Disease IVD Market Share by Country (2020-2031)

Figure 45. Mexico Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Neurodegenerative Disease IVD Market Share by Country (2020-2031)

Figure 49. Israel Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Neurodegenerative Disease IVD Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. ADx Neurosciences Revenue Growth Rate in Neurodegenerative Disease IVD Business (2020-2025)

Figure 53. Analytik Jena Revenue Growth Rate in Neurodegenerative Disease IVD Business (2020-2025)

Figure 54. Beckman Coulter Revenue Growth Rate in Neurodegenerative Disease IVD Business (2020-2025)

Figure 55. Creative Biolabs Revenue Growth Rate in Neurodegenerative Disease IVD Business (2020-2025)

Figure 56. Fujirebio Revenue Growth Rate in Neurodegenerative Disease IVD Business (2020-2025)

Figure 57. Genemedi Revenue Growth Rate in Neurodegenerative Disease IVD Business (2020-2025)

Figure 58. Medix Biochemica Revenue Growth Rate in Neurodegenerative Disease IVD Business (2020-2025)

Figure 59. Revvity Revenue Growth Rate in Neurodegenerative Disease IVD Business (2020-2025)

Figure 60. Roche Diagnostics Revenue Growth Rate in Neurodegenerative Disease IVD Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions